Impact of consolidation radiotherapy in patients with advanced breast cancer treated with high-dose chemotherapy and autologous bone marrow rescue

Journal of Clinical Oncology

Volumn 17, Issue 3, 1999, Pages 887-893

  Carter, Dennis L ^a   Marks, Lawrence B ^a   Bean, Joseph M ^a   Broadwater, Gloria ^a   Hussein, Atif ^a   Vredenburgh, James J ^a   Peters, William P ^a   Prosnitz, Leonard R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE;

ADULT; AGE; ARTICLE; BONE MARROW RESCUE; BRAIN DISEASE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HEPATITIS; HUMAN; LUNG INJURY; MAJOR CLINICAL STUDY; NEUTROPENIA; PNEUMONIA; PRIORITY JOURNAL; SEPSIS; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT FAILURE;

EID: 0033044210     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.3.887     Document Type: Article

References (33)

1. Tsuruo T, Fidler IJ: Differences in drug sensitivity among tumor cells from parental tumors, selected variants, and spontaneous metastases. Cancer Res 41:3058-3064, 1981
2. Frei E, Canellos GC: Dose: A critical factor in cancer therapy. Am J Med 69:585-594, 1980
3. Hryniuk W, Bush H: The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 2:1281-1288, 1984
4. Ayash LJ, Wheeler C, Fairclough D. et al: Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer. J Clin Oncol 13:2043-2049, 1995
5. Eddy DM: High-dose chemotherapy with autologous bone marrow transplantation for the treatment of metastatic breast cancer. J Clin Oncol 10:657-670, 1992
6. Bezwoda WR, Seymour L, Dansey RD: High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: A randomized trial. J Clin Oncol 13:2483-2489, 1995
7. Rutqvist LE, Petersson D, Johansson H: Adjuvant radiation therapy versus surgery alone in operable breast cancer: Long-term follow-up of a randomized clinical trial. Radiother Oncol 26:104-110, 1993
8. Overgaard M, Hansen PS, Overgaard J, et al: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337:949-955, 1997
9. Ragaz J, Jackson SM, Le N, et al: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337:956-962, 1997
10. Oleson JE, Neuberg D, Pandya KH, et al: The role of radiotherapy in the management of operable locally advanced breast carcinoma. Cancer 79:1138-1149, 1997
11. Dombernowsky P, Hansen P, Mouridsen H, et al: Randomized trial of adjuvant CMF + radiotherapy (RT) vs CMF alone vs tamoxifen (TAM) in pre- and menopausal age stage II breast cancer. Ann Oncol 5:2, 1994 (suppl 8)
12. Rose C, Hansen P, Dombernowsky P, et al: A randomized trial of adjuvant (ADJ) tamoxifen (TAM) + radiotherapy (RT) vs TAM alone vs. TAM + CMF in postmenopausal stage II breast cancer. Eur J Cancer 30A:S28, 1994 (abstr)
13. Ahmann DL, O'Fallon JR, Scanlon PW, et al: A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on aggressiveness of therapy. Am J Clin Oncol 5:371-381, 1982
14. Griem KL, Henderson IC, Gelman R, et al: The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J Clin Oncol 5:1546-1555, 1987
15. Velez-Garcia E, Carpenter JT Jr, Moore M, et al: Postsurgical adjuvant chemotherapy with and without radiotherapy in women with breast cancer and positive axillary nodes: A South-Eastern Cancer Study Group (SEG) trial. Eur J Cancer 28A: 1833-1837, 1992
16. Muss HB, Cooper MR, Brockschmidt JK, et al: A randomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancer: Eleven-year follow-up of a Piedmont Oncology Association trial. Breast Cancer Res Treat 19:77-84, 1991
17. McArdle CS, Crawford D, Dykes EH, et al: Adjuvant radiotherapy and chemotherapy in breast cancer. Br J Surg 73:264-266, 1986
18. Blomqvist C, Tiusanen K, Elomaa I, et al: The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicinftorafur) and tamoxifen in stage II breast cancer: Long-term results of a randomised trial. Br J Cancer 66:1171-1176, 1992
19. Marks LB, Halperin EC, Prosnitz LR, et al: Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with a 10 positive axillary lymph nodes. Int J Radiat Oncol Biol Phys 23:1021-1026, 1992
20. Shah AB, Hartsell WF, Ghalie R, et al: Patterns of failure following bone marrow transplantation for metastatic breast cancer: The role of consolidative local therapy. Int J Radiat Oncol Biol Phys 32:1433-1438, 1995
21. Mundt AJ, Sibley GS, Williams S, et al: Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: Implications for the use of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 30:151-160, 1994
22. Tiersten A, Raptis G, Crown J, Hamilton N, et al: Patterns of failure following high dose chemotherapy (HDC) with peripheral blood progenitor cell support in patients with metastatic breast cancer. Proc Am Soc Clin Oncol 15:338, 1996 (abstr979)
23. Peters WP, Jones RB, Vredenburgh J, et al: A large, prospective, randomized trial of high-dose alkylating agents (CPB) with autologous cellular support (ABMS) as consolidation for patients with metastatic breast cancer achieving complete remission after intensive doxorubicin-based induction therapy (AFM). Proc Am Soc Clin Oncol 15:121, 1996 (abstr 149)
24. Hellman S, Weichselbaum RR: Oligometastases. J Clin Oncol 13:3-10, 1995 (editorial)
25. Marks LB, Prosnitz LR: Is there a role for radiotherapy in the "curative" management of patients with metastatic cancer? Int J Radiat Oncol Biol Phys 30:243-244, 1994
26. Aviles A, Delgado S, Nambo MJ, et al: Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma. Int J Radiat Oncol Biol Phys 30:799-803, 1994
27. Wu JJ, Prosnitz LR: The role of adjuvant radiation therapy for stages III and IV Hodgkin's disease. Semin Radiat Oncol 6:1-15, 1996
28. Castleberry RP, Kun LE, Shuster JJ, et al: Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma. J Clin Oncol 9:789-795, 1991
29. Kushner BH, O'Reilly RJ, Mandell LR, et al: Myeloablative combination chemotherapy without total body irradiation for neuroblastoma. J Clin Oncol 9:274-279, 1991
30. Jones RB, Shpall EJ, Shogan J, et al: The Duke AFM Program: Intensive induction chemotherapy for metastatic breast cancer. Cancer 66:431-436, 1990
31. Marks LB, Rosner GL, Prosnitz LR, et al: The impact of conventional plus high-dose chemotherapy with autologous bone marrow transplantation on hematologic toxicity during subsequent local-regional radiotherapy for breast cancer. Cancer 74:2964-2971, 1994
32. Harris JR, Lipman ME, Morrow M, Hellman S: Diseases of the Breast. Philadelphia, PA, Lippincott, 1996, pp 532-537
33. Jamieson TA, Carter DL, Prosnitz LR, et al: Predictors for pneumonitis during local-regional radiotherapy in patients with advanced breast cancer previously treated with high dose chemotherapy and bone marrow transplant. Int J Radiat Oncol Biol Phys 39:260, 1997 (ASTRO suppl 2S, abstr 2040)